Dr. Alan Wu Honored with 2026 ADLM Outstanding Lifetime Achievement Award in Clinical Chemistry
Major National Recognition in Laboratory Medicine
The Association for Diagnostics & Laboratory Medicine (ADLM) has named Dr. Alan Wu as the recipient of its 2026 Outstanding Lifetime Achievement Award in Clinical Chemistry and Laboratory Medicine. The distinction serves as the premier accolade bestowed by the international professional organization, honoring sustained, exemplary contributions across research, education, and clinical service in diagnostic healthcare.
Dr. Wu serves as co-core laboratory director at Zuckerberg San Francisco General Hospital and as a professor of laboratory medicine at the University of California, San Francisco (UCSF). Over a career spanning several decades, his research has driven advance in clinical toxicology, cardiac biomarkers, pharmacogenomics, point-of-care testing, traumatic brain injury, and sepsis diagnostics.
Decades of Scientific Leadership and Mentorship
Throughout his academic career, Dr. Wu has authored or co-authored more than 800 scientific publications in peer-reviewed journals and technical literature. In addition to his research output, his institutional contributions include the training of hundreds of pathology and laboratory medicine residents, clinical laboratory science students, and more than 40 postdoctoral fellows through programs accredited by the Commission on Accreditation in Clinical Chemistry.
Before his appointment at UCSF and San Francisco General Hospital, Dr. Wu held key academic and clinical laboratory leadership positions at the University of Texas Health Science Center, Hermann Hospital in Houston, Hartford Hospital, and the University of Connecticut. He holds undergraduate degrees in chemistry and biology from Purdue University and earned his Ph.D. in analytical chemistry from the University of Illinois prior to completing a postdoctoral fellowship at Hartford Hospital.
Impact on Patient Care and Clinical Practice
The ADLM Lifetime Achievement Award recognizes professionals whose careers have significantly strengthened diagnostic accuracy and improved real-world patient care standards. Dr. Wu's work in establishing rapid biomarker testing and point-of-care diagnostic protocols has contributed to faster diagnostic response times in critical care environments, particularly for cardiac events and acute toxicological exposures.
Formal recognition for Dr. Wu and fellow 2026 ADLM merit award winners took place during the organization's Annual Scientific Meeting, celebrating international leaders whose technical rigor advances the broader field of medicine.